10864 related articles for article (PubMed ID: 11706778)
21. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
22. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
Søndergaard K
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
[TBL] [Abstract][Full Text] [Related]
23. Nodular melanoma in 62 Japanese patients: influence of initial surgical treatment on local recurrence and prognosis.
Kato T; Suetake T; Kumasaka N; Tabata N; Sugiyama Y; Tagami H
J Dermatol; 1995 Oct; 22(10):723-8. PubMed ID: 8586749
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of level V malignant melanoma.
Bear HD; Neifeld JP; Kay S
Cancer; 1985 Mar; 55(6):1167-71. PubMed ID: 3971289
[TBL] [Abstract][Full Text] [Related]
25. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
[TBL] [Abstract][Full Text] [Related]
26. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
28. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
[TBL] [Abstract][Full Text] [Related]
29. [Statistical review of Malignant melanoma and its precancerous condition].
Ueda M; Mishima Y
Nihon Rinsho; 1993 Jan; 51 Suppl():852-60. PubMed ID: 8459622
[No Abstract] [Full Text] [Related]
30. Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute.
Otsuka M; Yamasaki O; Kaji T; Iwatsuki K; Asagoe K
J Dermatol; 2015 Oct; 42(10):954-61. PubMed ID: 26074328
[TBL] [Abstract][Full Text] [Related]
31. Malignant melanoma of the vulva. Report of 89 patients.
Räber G; Mempel V; Jackisch C; Hundeiker M; Heinecke A; Kürzl R; Glaubitz M; Rompel R; Schneider HP
Cancer; 1996 Dec; 78(11):2353-8. PubMed ID: 8941006
[TBL] [Abstract][Full Text] [Related]
32. The importance of anatomic site in prognosis in patients with cutaneous melanoma.
Wong JH; Wanek L; Chang LJ; Goradia T; Morton DL
Arch Surg; 1991 Apr; 126(4):486-9. PubMed ID: 2009064
[TBL] [Abstract][Full Text] [Related]
33. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
[TBL] [Abstract][Full Text] [Related]
34. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
Kapelanski DP; Block GE; Kaufman M
Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma: basic approach to clinicopathologic correlation.
Su WP
Mayo Clin Proc; 1997 Mar; 72(3):267-72. PubMed ID: 9070204
[TBL] [Abstract][Full Text] [Related]
38. Malignant Melanoma in Lagos, Nigeria: Elucidating Histopathologic Prognostic Factors.
Obadofin OO; Badmos KB; Omoseebi OO; Banjo AAF
West Afr J Med; 2022 Jun; 39(6):623-627. PubMed ID: 35752963
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological Study of Malignant Melanoma at Tertiary Care Centre.
Thapa S; Ghosh A; Ghartimagar D; Prasad T; Narasimhan R; Talwar O
JNMA J Nepal Med Assoc; 2017; 56(205):132-136. PubMed ID: 28598449
[TBL] [Abstract][Full Text] [Related]
40. Comparison Among Clark's, Breslow's, and TNM classifications for cutaneous head and neck malignant melanoma.
Morselli P; Masciotra L; Pinto V; Zollino I; Brunelli G; Carinci F
J Craniofac Surg; 2007 Nov; 18(6):1353-8. PubMed ID: 17993881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
